Work

Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment

Year: 2026
Type: article
Abstract: Using biomarker test results from a patient’s medical record or testing by a local clinical site can accelerate trial enrollment when compared with using a trial sponsor’s clinical trial assay or candidate companion diagnostic provided by central laboratories. However, doing so may create technical, operational, and regulatory complexities for sponsors. A risk-based framework can inform sponsor decisions and awareness of risks and benefits as interest in using local tests increases.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,090
OpenAlex ID: W7236002251
FWCI:
Cites: 13
Cited by:
Related to: 10